Contact Us
Viral Vector Production (Research-Use) Global Market Report 2025
Global Viral Vector Production (Research-Use) Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Viral Vector Production (Research-Use) Global Market Report 2025

By Type (Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types); By Production (Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods); By Workflow (Upstream Processing, Downstream Processing); By Application (Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications); By End-Use (Pharmaceutical And Biopharmaceutical Companies, Research Institutes); Subsegments:; By Adeno-Associated Virus (Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus); By Other Types (Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Viral Vector Production (Research-Use) Market Overview

• Viral Vector Production (Research-Use) market size has reached to $1.54 billion in 2024

• Expected to grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15%

• Growth Driver: Rising Occurrence Of Genetic Disorders Fueling The Growth Of The Market Due To Advanced Parental Age And Gene Therapy Demand

• Market Trend: Technological Innovation In Viral Vector Production Enhances Research Efficiency And Scalability

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Vector Production (Research-Use) Market?

Viral vector production (research-use) refers to the laboratory-based process of generating modified viruses that can efficiently deliver genetic material into target cells for experimental purposes. These vectors are engineered to be replication-deficient and safe for use in controlled research environments. The process involves vector design, production in host cells, and purification to ensure quality, safety, and effectiveness in scientific studies.

The main types of viral vector production (research-use) are Adeno-Associated Virus (AAV), lentivirus, adenovirus, retrovirus, and others. Adeno-associated viruses are tiny viruses that carry genetic information to cells; they are members of the Parvoviridae family and cannot reproduce independently, instead relying on other viruses. The various production methods include transient transfection, stable cell lines, viral packaging systems, and others by various workflows, including upstream processing and downstream processing. The different applications include gene therapy, vaccines, oncology, infectious diseases, and others and are used for several end-users, including pharmaceutical and biopharmaceutical companies and research institutes.

Viral Vector Production (Research-Use) Market Size and growth rate 2025 to 2029: Graph

What Is The Viral Vector Production (Research-Use) Market Size 2025 And Growth Rate?

The viral vector production (research-use) market size has grown rapidly in recent years. It will grow from $1.54 billion in 2024 to $1.77 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the growth of basic genetic and cell biology research, the rise in infectious disease research, the widespread use of viral vectors in CRISPR and RNAi studies, the increasing demand from cancer immunotherapy studies, and the increasing academic interest and initial clinical trials in gene therapy.

What Is The Viral Vector Production (Research-Use) Market Growth Forecast?

The viral vector production (research-use) market size is expected to see rapid growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the rising burden of genetic disorders, the growing preclinical gene therapy pipeline, the growing use in regenerative medicine studies, increasing research on neurodegenerative diseases, and increasing rare disease research funding. Major trends in the forecast period include advancements in gene therapy research, automation in vector quality control (QC), hybrid and chimeric vector development, automation in upstream and downstream processes, and synthetic biology-based vector modificatio

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Viral Vector Production (Research-Use) Market Segmented?

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Is Driving The Viral Vector Production (Research-Use) Market? Rising Occurrence Of Genetic Disorders Fueling The Growth Of The Market Due To Advanced Parental Age And Gene Therapy Demand

The rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) market going forward. Genetic disorders are diseases or conditions caused by abnormalities in an individual's deoxyribonucleic acid, which can be inherited from one or both parents or occur due to new genetic mutations. The rise in genetic disorders is due to increasing parental age, raising the likelihood of genetic mutations being passed to offspring. The growing prevalence of genetic disorders supports the growth of viral vector production (research-use) by driving demand for advanced gene delivery tools to study disease mechanisms and develop potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) industry.

Who Are The Major Players In The Global Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, and Mustang Bio Inc.

What Are The Key Trends Of The Global Viral Vector Production (Research-Use) Market? Technological Innovation In Viral Vector Production Enhances Research Efficiency And Scalability

Major companies operating in the viral vector production market are focusing on developing advanced solutions, such as specialized cell culture media, to improve transfection efficiency, increase viral vector yields, and ensure consistent quality for research applications. Cell culture media are nutrient-rich solutions designed to support the growth and maintenance of cells outside their natural environment. They contain essential components like amino acids, vitamins, and growth factors optimized for specific cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, introduced BalanCD HEK293 Viral Feed, the world’s first chemically defined nutrient feed specifically optimized for HEK293 suspension cultures used in AAV viral vector manufacturing. Through this launch, the company aims to significantly boost adeno-associated virus (AAV) yields, with up to 67% improvement in viral packaging efficiency compared to basal media. The feed is designed for scalable gene therapy and biotech workflows, offering consistent performance across formats and compatibility with multiple media systems.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Viral Vector Production (Research-Use) Market? Altis Labs Inc. Partnered With Astrazeneca And Bayer Pharmaceuticals To Accelerate Clinical Trials Using AI-Powered Digital Twins

In January 2024, Oxford Biomedica Plc, a UK-based gene and cell therapy company, acquired ABL Europe for an undisclosed amount. With this acquisition, Oxford Biomedica aims to expand its presence in the European market and enhance its contract development and manufacturing organization (CDMO) offerings, particularly in the field of viral vector manufacturing. ABL Europe is a France-based company specializing in the development and production of viral vectors.

What Is The Regional Outlook For The Global Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market consists of sales of baculovirus, herpes simplex virus (HSV), vaccinia virus, vesicular stomatitis virus (VSV), hybrid viral vectors, and measles virus vectors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Viral Vector Production (Research-Use) Industry?

The viral vector production (research-use) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector production (research-use) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Table Of Contents

1. Executive Summary

2. Viral Vector Production (Research-Use) Market Characteristics

3. Viral Vector Production (Research-Use) Market Trends And Strategies

4. Viral Vector Production (Research-Use) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Vector Production (Research-Use) Growth Analysis And Strategic Analysis Framework

5.1. Global Viral Vector Production (Research-Use) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Viral Vector Production (Research-Use) Market Growth Rate Analysis

5.4. Global Viral Vector Production (Research-Use) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Viral Vector Production (Research-Use) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Viral Vector Production (Research-Use) Total Addressable Market (TAM)

6. Viral Vector Production (Research-Use) Market Segmentation

6.1. Global Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adeno-Associated Virus (AAV)

Lentivirus

Adenovirus

Retrovirus

Other Types

6.2. Global Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Transient Transfection

Stable Cell Line

Viral Packaging System

Other Production Methods

6.3. Global Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Upstream Processing

Downstream Processing

6.4. Global Viral Vector Production (Research-Use) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Vaccines

Oncology

Infectious Diseases

Other Applications

6.5. Global Viral Vector Production (Research-Use) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biopharmaceutical Companies

Research Institutes

6.6. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adeno-Associated Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Stranded Adeno-Associated Virus

Self-Complementary Adeno-Associated Virus

Hybrid Adeno-Associated Virus

6.7. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Lentivirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Immunodeficiency Virus-Based Lentivirus

Feline Immunodeficiency Virus-Based Lentivirus

Equine Infectious Anemia Virus-Based Lentivirus

6.8. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adenovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Replication-Competent Adenovirus

Replication-Deficient Adenovirus

Helper-Dependent Adenovirus

6.9. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Retrovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gamma Retrovirus

Spumavirus (Foamy Virus)

Alpha Retrovirus

6.10. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Herpes Simplex Virus Vectors

Baculovirus Vectors

Sendai Virus Vectors

7. Viral Vector Production (Research-Use) Market Regional And Country Analysis

7.1. Global Viral Vector Production (Research-Use) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Viral Vector Production (Research-Use) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Vector Production (Research-Use) Market

8.1. Asia-Pacific Viral Vector Production (Research-Use) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Vector Production (Research-Use) Market

9.1. China Viral Vector Production (Research-Use) Market Overview

9.2. China Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Vector Production (Research-Use) Market

10.1. India Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Vector Production (Research-Use) Market

11.1. Japan Viral Vector Production (Research-Use) Market Overview

11.2. Japan Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Vector Production (Research-Use) Market

12.1. Australia Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Vector Production (Research-Use) Market

13.1. Indonesia Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Vector Production (Research-Use) Market

14.1. South Korea Viral Vector Production (Research-Use) Market Overview

14.2. South Korea Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Vector Production (Research-Use) Market

15.1. Western Europe Viral Vector Production (Research-Use) Market Overview

15.2. Western Europe Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Vector Production (Research-Use) Market

16.1. UK Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Vector Production (Research-Use) Market

17.1. Germany Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Vector Production (Research-Use) Market

18.1. France Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Vector Production (Research-Use) Market

19.1. Italy Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Vector Production (Research-Use) Market

20.1. Spain Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Vector Production (Research-Use) Market

21.1. Eastern Europe Viral Vector Production (Research-Use) Market Overview

21.2. Eastern Europe Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Vector Production (Research-Use) Market

22.1. Russia Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Vector Production (Research-Use) Market

23.1. North America Viral Vector Production (Research-Use) Market Overview

23.2. North America Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Vector Production (Research-Use) Market

24.1. USA Viral Vector Production (Research-Use) Market Overview

24.2. USA Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Vector Production (Research-Use) Market

25.1. Canada Viral Vector Production (Research-Use) Market Overview

25.2. Canada Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Vector Production (Research-Use) Market

26.1. South America Viral Vector Production (Research-Use) Market Overview

26.2. South America Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Vector Production (Research-Use) Market

27.1. Brazil Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Vector Production (Research-Use) Market

28.1. Middle East Viral Vector Production (Research-Use) Market Overview

28.2. Middle East Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Vector Production (Research-Use) Market

29.1. Africa Viral Vector Production (Research-Use) Market Overview

29.2. Africa Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Vector Production (Research-Use) Market Competitive Landscape And Company Profiles

30.1. Viral Vector Production (Research-Use) Market Competitive Landscape

30.2. Viral Vector Production (Research-Use) Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Viral Vector Production (Research-Use) Market Other Major And Innovative Companies

31.1. Sartorius AG

31.2. Charles River Laboratories International Inc.

31.3. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

31.4. Curia Inc.

31.5. AGC Biologics GmbH

31.6. SK pharmteco Inc.

31.7. Oxford Biomedica Plc

31.8. Waisman Biomanufacturing

31.9. Voyager Therapeutics Inc.

31.10. FinVector Oy

31.11. Batavia Biosciences BV.

31.12. GENEZEN LABORATORIES

31.13. BioNTech IMFS GmbH

31.14. VGXI Inc.

31.15. Tonix Pharmaceuticals

32. Global Viral Vector Production (Research-Use) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector Production (Research-Use) Market

34. Recent Developments In The Viral Vector Production (Research-Use) Market

35. Viral Vector Production (Research-Use) Market High Potential Countries, Segments and Strategies

35.1 Viral Vector Production (Research-Use) Market In 2029 - Countries Offering Most New Opportunities

35.2 Viral Vector Production (Research-Use) Market In 2029 - Segments Offering Most New Opportunities

35.3 Viral Vector Production (Research-Use) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Viral Vector Production (Research-Use) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Viral Vector Production (Research-Use) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adeno-Associated Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Lentivirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adenovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Retrovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Viral Vector Production (Research-Use) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Viral Vector Production (Research-Use) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Sanofi S.A. Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Merck KGaA Financial Performance
  • Table 84: Becton, Dickinson and Company Financial Performance
  • Table 85: Lonza Group AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Viral Vector Production (Research-Use) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Viral Vector Production (Research-Use) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adeno-Associated Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Lentivirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adenovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Retrovirus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Viral Vector Production (Research-Use) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Viral Vector Production (Research-Use) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Sanofi S.A. Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Merck KGaA Financial Performance
  • Figure 84: Becton, Dickinson and Company Financial Performance
  • Figure 85: Lonza Group AG Financial Performance

Frequently Asked Questions

Viral vector production (research-use) refers to the laboratory-based process of generating modified viruses that can efficiently deliver genetic material into target cells for experimental purposes. These vectors are engineered to be replication-deficient and safe for use in controlled research environments. The process involves vector design, production in host cells, and purification to ensure quality, safety, and effectiveness in scientific studies. For further insights on this market, request a sample here

The market major growth driver - Rising Occurrence Of Genetic Disorders Fueling The Growth Of The Market Due To Advanced Parental Age And Gene Therapy Demand. For further insights on this market, request a sample here

The viral vector production (research-use) market size has grown rapidly in recent years. It will grow from $1.54 billion in 2024 to $1.77 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the growth of basic genetic and cell biology research, the rise in infectious disease research, the widespread use of viral vectors in CRISPR and RNAi studies, the increasing demand from cancer immunotherapy studies, and the increasing academic interest and initial clinical trials in gene therapy. The viral vector production (research-use) market size is expected to see rapid growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the rising burden of genetic disorders, the growing preclinical gene therapy pipeline, the growing use in regenerative medicine studies, increasing research on neurodegenerative diseases, and increasing rare disease research funding. Major trends in the forecast period include advancements in gene therapy research, automation in vector quality control (QC), hybrid and chimeric vector development, automation in upstream and downstream processes, and synthetic biology-based vector modificatio For further insights on this market, request a sample here

The viral vector production (research-use) market covered in this report is segmented as
1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types
2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications
5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes Subsegments:
1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus
2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus
3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus
4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus
5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors For further insights on this market,
request a sample here

North America was the largest region in the virtual vector production (research-use) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector production (research-use) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, and Mustang Bio Inc. For further insights on this market, request a sample here.

Major trends in this market include Technological Innovation In Viral Vector Production Enhances Research Efficiency And Scalability For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon